Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial

David Planchard, Tae Min Kim, Julien Mazieres, Elisabeth Quoix, Gregory Riely, Fabrice Barlesi, Pierre-Jean Souquet, Egbert F. Smit, Harry J. M. Groen, Ronan J. Kelly, B. C. Cho, Mark A. Socinski, Lini Pandite, Christine Nase, Bo Ma, Anthony, Jr. D'Amelio, Bijoyesh Mookerjee, C. Martin, Jr. Curtis, Bruce E. Johnson

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)642-650
JournalLancet Oncology
Volume17
Issue number5
DOIs
Publication statusPublished - May 2016

Cite this